Small Molecule Drug Discovery Market

Small molecule drugs have represented some of the crucial blockbusters in the history of the pharmaceutical industry. Defined as any organic compound with low molecular weight, small molecule drugs have some distinct advantages as therapeutics. Small molecule drugs capable of modulating biochemical processes to diagnose, treat, and prevent diseases. Small molecule drugs are the mainstay of medicine, representing around 90 percent of all approved medicines and 75 percent of all new medicines approved in the U.S. in 2020.

Market Dynamics:

High prevalence of chronic diseases, increase in demand for small molecule drugs, rise in focus on small molecule drug discovery, increasing number of contract organizations, and increase in research and development activities are some major factors expected to augment the growth of the global small molecule drug discovery market.

In July 2022, RxCelerate revealed details of a new small molecule discovery platform, named RxNfinity, which leverages machine learning, in silico structure modeling and combinatorial chemistry in a novel workflow that offers significant advantages over the current generation of tools to identify small molecule drugs against a wide range of protein targets.

In July 2022, Dotmatics announced the release of its Small Molecule Drug Discovery Solution, an integrated scientific research and development platform with pre-configured workflows and expanded data management capabilities. The new solution will help companies innovate more easily by leveraging best practices derived from Dotmatics’ 15+ years of experience supporting small molecule drug discovery.

Key features of the study:

• This report provides in-depth analysis of the global small molecule drug discovery market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022–2028), considering 2021 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global small molecule drug discovery market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Teva Pharmaceuticals, Merck KgaA, Johnson & Johnson, GlaxoSmithKline PLC, Gilead Sciences Inc., AstraZeneca, Immunocure Inc., Acacia Pharma Gr, 4SC AG, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, 21st Century Therapeutics, Novartis, Pfizer Inc., and Takeda Pharmaceutical Industries Ltd., among others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global small molecule drug discovery market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global small molecule drug discovery market.

Detailed Segmentation:

• Global Small Molecule Drug Discovery Market, By Therapeutic Area:
• • Oncology
  • Central Nervous System
  • Cardiovascular
  • Respiratory
  • Metabolic Disorders
  • Gastrointestinal
  • Other Therapeutic Areas
• Global Small Molecule Drug Discovery Market, By Process/Phase:
• • Target ID/Validation
  • Hit Generation and Selection
  • Lead Identification
  • Lead Optimization
• Global Small Molecule Drug Discovery Market, By Geography:
• • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East and Africa
• Company Profiles:
• • Teva Pharmaceuticals
  • Merck KgaA
  • Johnson & Johnson
  • GlaxoSmithKline PLC
  • Gilead Sciences Inc.
  • AstraZeneca
  • Immunocure Inc.
  • Acacia Pharma Gr
  • 4SC AG
  • Boehringer Ingelheim GmbH
  • Bristol-Myers Squibb Company
  • 21st Century Therapeutics Inc.
  • Novartis
  • Pfizer Inc.
  • Takeda Pharmaceutical Industries Ltd.